Jeito Capital becomes a significant investor in HI-Bio, a clinical-stage biotech company developing targeted therapies for patients with severe immune-mediated diseases                                                             Jeito Capital becomes a significant investor in HI-Bio, a clinical-stage biotech company developing targeted therapies for patients with...

AviadoBioTM Raises $80 million in Series A Financing to Advance Neurodegenerative Gene Therapy Platform AviadoBioTM Raises $80 million in Series A Financing to Advance Neurodegenerative Gene Therapy Platform Series A led by New Enterprise Associates (NEA) and co-led by Monograph Capital follows...